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Embryonic poly(A) binding protein (EPAB), expressed in oocytes and early embryos, binds and stabilizes maternal mRNAs, and
mediates initiation of their translation. We identiﬁed an alternatively spliced form of Epab lacking exon 10 (c.Ex10del) and inves-
tigated the regulation of Epab mRNA alternative splicing as a model for alternative splicing in oocytes and early preimplantation
embryos. Speciﬁcally, we evaluated the following mechanisms: imprinting; RNA editing and exonic splicing enhancers (ESEs).
Sequence analysis led to the identiﬁcation of two single nucleotide polymorphisms (SNPs): one was detected in exon 9
(rs55858A/G), and served as a marker for the parental origin of the alternatively spliced form, and the other was found in
exon 10 (rs56574G/C), and co-segregated with the exon 9 SNP. We found that the presence of rs56574G in exon 10 led to the for-
mation of an ESE, leading to efﬁcient exclusion of exon 10. Real-time RT–PCR results revealed a 5-fold increase in the expression
of the c.Ex10del alternative splicing variant in animals carrying rs56574G/G in exon 10 compared with rs56574C/C at the same
locus. Our ﬁndings suggest that SNPs may alter the ratio between alternative splicing variants of oocyte-speciﬁc proteins. The role
that these subtle differences play in determining individual reproductive outcome remains to be determined.
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Introduction
Post-transcriptional modiﬁcation of mRNAs by alternative splicing is
an important mechanism by which genomic complexity is generated
from the surprisingly low number of genes currently estimated from
the human genome sequence (Black, 2003; Faustino and Cooper,
2003). The fraction of human genes estimated to be subject to alterna-
tive splicing has risen from 5% in early predictions to at least 75% in a
recent genome-wide exon study (Gardina et al., 2006).
From a single gene, alternative splicing may result in the generation
of variable transcripts produced combinatorially through the selection
of cassette exons, mutually exclusive exons, alternative 30 or 50 splice
sites, alternative promoters or poly(A) sites, which in concert, result in
protein diversity (Black, 2003; Faustino and Cooper, 2003). There are
examples of hundreds of alternative splicing events from a single
gene, which may affect function by adding or deleting functional
domains, changing afﬁnities or altering mRNA stability (Babushok
et al., 2007). For example, in the case of ﬁbroblast growth factor
receptor, a portion of the ligand-binding domain of the receptor is
encoded by two alternative exons that are entirely responsible for
receptor’s interaction with different ligands (Givol and Yayon, 1992).
Regulation of mRNA processing is especially important in oocytes,
as oocyte maturation is associated with suppression of transcription
(Flach et al., 1982; Newport and Kirschner, 1982a,b; Braude et al.,
1988; Schultz, 2002) and new mRNAs are not synthesized until after
zygotic genome activation (ZGA) that occurs at the 4- to 8-cell stage
in human (Braude et al., 1988) and the 2-cell stage in mouse (Flach
et al., 1982). During the period of time that begins with oocyte matu-
rationandlasts untilZGA,gene expressionis mainlymediatedby acti-
vation and suppression of maternal mRNAs accumulated in the oocyte
priortomeioticreactivation(MendezandRichter,2001;Schier,2007).
Gametes express alternative proteins for RNA binding (Gu et al.,
1998; Voeltz etal., 2001; Seli etal., 2005), suggestingthatRNA meta-
bolism in gametes is tightly and differentially regulated. Although
gamete-speciﬁc RNA-regulatory proteins have been identiﬁed
(Voeltz et al., 2001; Seli et al., 2005), and alternative splicing of
gamete-speciﬁc genes have been described (Gu et al., 1998), mechan-
isms involved in the regulation of alternative splicing in gametes
remain to be elucidated.
Embryonic poly(A) binding protein (EPAB), identiﬁed in Xenopus
oocytes, is the predominant poly(A) binding protein (PABP) during
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quitous somatic cytoplasmic PABP (PABPC1) (Voeltz et al., 2001).
EPAB is the only factor identiﬁed to date in both known protein
complexes (cytoplasmic polyadenylation complex and PUMILIO-
2/DAZL/EPAB complex) that bind and stabilize dormant mRNAs
in immature oocytes (Padmanabhan and Richter, 2006; Kim and
Richter, 2007). EPAB also appears to be the only factor required for
both known pathways (cytoplasmic polyadenylation-dependent and
independent) that mediate maternal mRNA translational activation
upon oocyte maturation (Cao and Richter, 2002; Padmanabhan and
Richter, 2006; Vasudevan et al., 2006). Therefore, EPAB seems to
play a central role in the translational regulation of maternally
derived mRNAs during a critical period of early development when
transcription is suppressed. We have recently identiﬁed mouse Epab
expressed in oocytes and early embryos (Seli et al., 2005). Similar
to its Xenopus ortholog, mouse Epab is the predominant PABP until
ZGA, which occurs at the 2-cell stage in mouse (Seli et al., 2005).
In the current study, we identiﬁed an alternatively spliced form of
Epab lacking exon 10 (c.Ex10del) and investigated the regulation of
Epab alternative splicing as a model for alternative splicing in
oocytes and early preimplantation embryos. Speciﬁcally,we evaluated
the following mechanisms: imprinting (expression from maternal or
paternal allele only); RNA editing (post-transcriptional single nucleo-
tide substitution) and exonic splicing enhancers (ESEs, sites within an
exon that bind splicing proteins).
Materials and Methods
Animals
Adult C3H and C57Bl/6J mice were purchased from Jackson laboratories
(Bar Harbor, ME, USA). Mice were bred and maintained according to the
Yale University animal research requirements, and all procedures were
approved by the Institutional Animal Care and Use Committee (protocol
number # 2005-07222). Mice were fed at libitum and housed under a 12 h
light cycle.
DNA extraction and single nucleotide polymorphism genotyping
Mouse tail genomic DNA was extracted by standard methods (Laird et al.,
1991). Brieﬂy, tail tips were cut and digested overnight with proteinase K
(100 mg/ml) in 0.5 ml lysis buffer (100 mM Tris HCl pH 8.5, 5 mM EDTA,
0.2% SDS, 200 mM NaCl) at 558C with rocking. Following vortexing and cen-
trifugation to pellet hair, 0.5 ml of 100% isopropanol was added to the super-
natant and chromosomal DNA was aggregated into a visible clump by rocking
manually at room temperature. The DNA was then spooled and dissolved in
0.5 ml TE buffer.
Genotyping for exon 9 single nucleotide polymorphism (SNP), rs55858A/G
was performed by polymerase chain reaction (PCR) ampliﬁcation of DNA
using primers exon9F: 50-TCTACAGCCCAGGCTGTGTAC-30 and IVS9R:
50-TAGCAATTTAGCCAAAAGAGTTTC-30, followed by HaeIII restriction
enzyme digestion (New England Biolabs, Ipswich, MA, USA). Ampliﬁcations
were carriedout using35 cyclesof PCR,in whichtheinitial5 minfor denatura-
tion at 948C was followed by a touch-down program for 10 cycles of 928C/30 s,
658C/20 s (218C per cycle) and 728C/30 s and then 25 cycles of 928C/30 s,
558C/20 s and 728C/30 s, in a 50 ml reaction mix containing 1  PCR buffer
(Ambion, Austin, TX, USA), 125 mM dNTP, 0.5 mM primers and 1 unit of
SuperTaq polymerase (Ambion). Digested samples were run on a 2%
agarose gel and visualized by ethidium bromide staining.
Total RNA isolation, reverse transcription and PCR
Total RNA was isolated after homogenization of adult mouse ovaries in Trizol
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions
and kept at 2808C until use. RNA was treated for genomic DNA contami-
nation using DNase I (Ambion). The quality and concentration of the RNA
was determined by measuring the absorbance at 260 and 280 nm. Equal
amounts of total RNA (2 mg) were reverse-transcribed to cDNA using oligo
d(T) priming at 378C for 1 h (Omniscript, Qiagen, Valencia, CA, USA).
Then, PCRs were performed on cDNAs using Taq DNA polymerase
(Qiagen) with speciﬁc primer pairs ﬂanking the alternatively spliced exons
10 and 13, respectively, as described in Results. The sequences of primers
were: exon8F: 50-ACGAAACCGCTCTATGTGGCCC-30, exon11R: 50-TGG
GGACTCCAGCAATAA CAGAAGC-30 andexon14R: 50-CCAGGAACCCA-
CAGAGTTCAG-30, PCR conditions were as above.
Spliced and unspliced forms were gel fractionated in 1.5% agarose
and visualized by ethidium bromide staining. PCR fragments were
extracted from agarose gel using a gel extraction kit (Roche Applied
Science, Indianapolis, IN, USA) according to the manufacturer’s protocol, and
sequenced at the W.M. Keck Foundation Biotechnology Resource Laboratory
at Yale University. Sequencing results were compared with mouse Epab
genomic sequence using Sequencher software version 4.7 (Gene Codes, Ann
Arbor, MI, USA).
Quantitative real-time PCR
Gene expression studies by quantitative real-time PCR (qRT-PCR) were
carried out on an iCycler (Bio-Rad, Hercules, CA, USA). Tissue cDNA,
prepared as described above, was assayed in triplicate. Each experiment
was repeated three times and ﬁve mutant animals were compared with ﬁve
litter mate controls. Each 25 ml reaction contained 12.5 mlo f2   SybrGreen
supermix (Biorad), 0.4 mM of each primer and 1 ml of template.
In order to quantitate the expression of different splicing variants of Epab,t h e
following primers were used: exon9–11F: 50-GGAACCTCAGCTGTACACAG
TG-30, exon 12R: 50-CTGATGGCCAGGGACATACAC-30, exon10F: 50-AG
CCAGGTGCCT CACACGCAG-30, exon8F: 50-ACGAAACCGCTCTATG
TGGCCC-30 and exon9R: 50-CCTGGGGTCAGGTTGCATTGG-30. Expression
of the target gene was normalized to b-actin levels using primers 50-G
ACCTCTATGCAACACAGT-30 and 50-TTGCTGATCCACATCTGCT-30.T h e
DDCt (cycle threshold) method was used to calculate relative expression levels.
Results were reported as a fold change in gene expression between different
genotypes.
Database search of ESE element
The ESE ﬁnder program (version 2.0, http://rulai.cshl.edu/cgi-bin/tools/ESE3/
eseﬁnder.cgi?process=home) (Cartegni et al., 2003) (Cold Spring Harbor Lab-
oratory, NY, USA) was used to identify ESE consensus sequences.
Statistical analysis
Since the data from qRT-PCR were normally distributed (as determined by
Kolmogorov–Smirnov test), the Student t-test was used. Statistical calcu-
lations were performed using SigmaStat for Windows, version 3.0 (Jandel
Scientiﬁc Corp., San Rafael, CA, USA). Statistical signiﬁcance was deﬁned
as P , 0.05.
Results
Identiﬁcation of an additional splicing variant of mouse
Epab gene
A splicing variant of mouse Epab lacking exon 13 has previously been
reported (Seli et al., 2005) (Fig. 1A). In the present study, RT–PCR in
mouse ovary using primers on exons 8 and 11 revealed two Epab-
speciﬁc bands (Fig. 1B). Sequencing of the lower band revealed an
additional splicing variant of the Epab transcript lacking exon 10
(c.Ex10del).
Moreover, ampliﬁcation from exon 8 to exon 14 ﬂanking both alter-
natively spliced exons, produced four Epab-speciﬁc bands. Sequen-
cing revealed that these bands corresponded to the full-length Epab,
alternatively spliced forms lacking exon 10 or exon 13, alternatively
spliced form lacking both exons 10 and 13 and a heteroduplex band
(Fig. 1C). Domain analysis of the predicted protein revealed that the
alternatively spliced form of mouse Epab mRNA without exon 13
lacks the PABP domain, whereas the spliced form of Epab without
exon 10 encodes a full PABP domain (Fig. 2, Table I).
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expression
The mice used for the identiﬁcation of the c.Ex10del variant were
progeny of mated CH3 with C57Bl/6J mice and were heterozygous
for an exon 9 SNP (rs55858A/G). SNP genotyping was performed
as described in Materials and Methods, using genomic PCR with
primers 9F and IVS9R (Fig. 3A and B), followed by HaeIII digestion
(Fig. 3C and D). The presence of rs55858G created a new HaeIII site
and resulted in a 240 bp fragment, whereas the rs55858A generated
for a 307 bp fragment upon digestion (Fig. 3C and D). This SNP
allowed us to determine that, consistent with bi-allelic gene
expression observed for most genes, Epab mRNA containing exon
10 was expressed from both alleles (Fig. 4A). However, c.Ex10del
Epab was expressed only from the allele containing the rs55858A
at the exon 9 SNP (Fig. 4A). This observation could be
explained by three possible mechanisms: imprinting, RNA editing
or ESEs.
Mouse Epab exon 10 skipping is not mediated
by imprinting or RNA editing
To determine if monoallellic expression of c.Ex10del Epab is
mediated by imprinting, we examined heterozygous (rs55858A/G)
mice that inherited the rs55858A allele from either the mother or
the father (Fig. 4A and B). Regardless of the parental origin of the
allele, the shorter Epab transcript lacking exon 10, contained the
rs55858A SNP, ruling out imprinting as the regulatory mechanism
(Fig. 4A and B).
Next, we tested the possibility of RNA editing mechanism, which is
a post-transcriptional base substitution (C to U, A to I) catalyzed by
enzymes called RNA-editing deaminases (Maydanovych and Beal,
2006). We bred homozygous (rs55858G/G) mice for the exon 9
SNP. In mice homozygous rs55858G/G SNP, we found that the
c.Ex10del variant also contained (G). Therefore, while in mice hetero-
zygous for the exon 9 SNP (rs55858A/G), exon 10 skipping preferen-
tially occurred from the rs55858A allele (Fig. 4A and B), alternative
splicing still occurred when both alleles contained G (rs55858G/G)
at position rs55858 (Fig. 4C). Consequently, RNA editing mechanism
was eliminated.
Mouse Epab exon 10 skipping is regulated by an ESE
To identify the origin of the monoallelic exon skipping, we performed
further sequence analysis and identiﬁed an additional SNP in exon 10
(rs56574G/C) that co-segregated with the exon 9 SNP (rs55858A/G).
The two SNPs are in ‘linkage disequilibrium’ as rs55858A allele in
Table I. Pattern search and multiple alignment of mouse, human and Xenopus PABPs.
Gene RRM1 Score RRM2 Score RRM3 Score RRM4 Score PABP Score
Mouse EPAB (full length) 13–84 aa 6.6e-27 101–170 aa 4e-23 193–263 aa 2.2e-27 296–365 aa 4.7e-23 524–595 aa 1.3e-20
Mouse EPAB (2exon 13) 13–84 aa 6.6e-27 101–170 aa 4e-23 193–263 aa 2.2e-27 296–365 aa 4.7e-23 Absent
Mouse EPAB (2exon 10) 13–84 aa 6.6e-27 101–170 aa 4e-23 193–263 aa 2.2e-27 296–365 aa 4.7e-23 524–595 aa 1.3e-20
Mouse EPAB (2exon 10/13) 13–84 aa 6.6e-27 101–170 aa 4e-23 193–263 aa 2.2e-27 296–365 aa 4.7e-23 Absent
Xenopus EPAB 13–84 aa 9.7e-25 101–170 aa 2.8e-24 193–263 aa 5.7e-26 296–365 aa 8.7e-22 540–611 aa 8.6e-42
Mouse PABPC1 13–84 aa 6.6e-27 101–170 aa 9e-25 193–263 aa 1.2e-30 296–365 aa 1.7e-23 543–614 aa 4.7e-47
Xenopus PABPC1 13–84 aa 5.4e-27 101–170 aa 8.8e-25 193–263 aa 6.1e-27 296–365 aa 4.1e-22 541–612 aa 1.3e-47
Human PABPC1 13–84 aa 3e-27 101–170 aa 9.2e-25 193–263 aa 7.5e-31 296–365 aa 1.8e-23 543–614 aa 9.5e-48
The positions of each structural motif and their similarity to the consensus are shown. The prediction and assignment of the protein structures were performed
by using PFAM (http:_pfam.wustl.edu). Shown are expected values (e values) that describe the number of hits one can expect to see by chance when searching
a database of a particular size. An e value of 1 assigned to a hit can be interpreted as meaning that, in a database of the current size, one might expect to see
one match with a similar score simply by chance. The lower the e value is the higher the signiﬁcance of the match.
PABP, poly(A) binding protein; RRM, RNA recognition motifs.
Figure 1: Alternatively spliced forms of Epab.
(A) The genomic structure of the mouse Epab gene consists of 14 exons. Exons
10 and 13 are alternatively spliced. (B) PCR on mouse ovary cDNA with
exon8F–exon11R primers detects the expression of alternatively spliced
Epab mRNA variants with (band 1) and without (band 2) exon 10. The size
of the lowest band is consistent with unbound primers. (C) PCR on mouse
ovary cDNA with exon8F-exon14R primers detects expression of alternatively
spliced Epab mRNA variants with and without exon 10 and/or 13. Four Epab
speciﬁc bands were detected by agarose gel fractionation. Sequencing revealed
that these bands corresponded to the full-length cDNA (band 1), a heteroduplex
band that consists of full-length cDNA paired with the alternatively spliced
form lacking exon 10 or 13 (band 2), alternatively spliced form lacking exon
10 or exon 13 (band 3) and alternatively spliced form lacking both exon 10
and exon 13 (band 4).
Figure 2: Schematic representation of predicted mouse Epab protein encoded
by full-length Epab mRNA, and alternatively spliced forms excluding exon 10,
exon 13 or exon 10/13.
The four RRM (1–4) are indicated by gray boxes, and the PABP domain in the
C-terminal region is indicated by a black box. Since the PABP domain is
encoded by exons 12 and 13, the (2ex 13) and (2ex 10/13) forms contain
only part of the PABP motif. The carboxy termini of the (2ex 13) and (2ex
10/13) forms also differ because of shifting of the exon 14 reading frame,
whereas the absence of exon 10 does not result in a frame shift.
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and rs55858G on exon 9 with rs56574C on exon 10.
Preferential splicing can be regulated by the presence of ESEs
within the sequence. To identify ESEs that are recognized by
individual splicing regulatory proteins (SF2/ASF, SC35, SRp40 and
SRp55), we used the ESE ﬁnder program version 2.0 (http://rulai.
cshl.edu/cgi-bin/tools/ESE3/eseﬁnder.cgi?process=home). In this
program, consensus motifs obtained with the four SR proteins are
detected and the thresholds represent values above which a score for
a given sequence is considered to be signiﬁcant (high score motif).
In silico analysis using ESE ﬁnder program revealed that the presence
of rs56574G leads to the formation of a consensus sequence
[CCTGAGG] characteristic of an ESE that binds splicing regulatory
protein SRp40, resulting in efﬁcient exclusion of exon 10, as the
binding afﬁnity of SRp40 protein for the CCTGAGG sequence is
3.19 whereas it is lower than thresholds value for CCTGAGC
sequence.
Presence of rs56574G in exon 10 is associated with a 5-fold
increase in the Epab c.ex10del variant without a change in
total epab expression
The effect of the ESE on the efﬁciency of alternative splicing in differ-
ent genetic backgrounds was evaluated by qRT-PCR. Mouse strain
C57BL/6 is homozygous for rs55858A and rs56574G alleles, and
C3H is homozygous for rs55858G and rs56574C alleles.
In order to quantitate the expression of the c.Ex10del variant, we
used a forward primer (exon9–11F) that was complementary to
exon 9 at its 50 end and to exon 11 at its 30 end, and would not
amplify Epab mRNA that contains exon 10. Reverse primer
(exon12R)was in exon 12.Thisprimer setresulted in a robust andsen-
sitive qRT-PCR reaction with a correlation coefﬁcient of 0.942, and a
slope of –3.356, corresponding to PCR efﬁciency of 98.6%.
Expression of Epab that contains exon 10 was quantiﬁed using
primers on exons 10 and 12 (exon10F and exon12R). This PCR reac-
tion had a standard curve with a correlation coefﬁcient of 0.999, a
slope of 23.395 and a PCR efﬁciency of 97%. Total Epab mRNA
expression (including all forms) was quantiﬁed using forward and
reverse primers at exons 8 and 9, respectively. This resulted in a stan-
dard curve with a correlation coefﬁcient of 0.99, a slope of –3.310 and
a PCR efﬁciency of 99.5%.
Quantitative RT-PCR revealed a 5-fold increase in the amount of
the c.Ex10del variant in the animals carrying the enhancer (homo-
zygous rs56574G/G) for the exon 10 SNP compared with the
mice that did not (homozygous rs56574C/C) at the same locus
(P , 0.001) (Fig. 5A). This was accompanied by a decrease in
the amount of the unspliced Epab transcript in the animals that
contained the ESE compared with mice that did not have the ESE
(P , 0.01) (Fig. 5B). There was no signiﬁcant difference in the
Figure 3: SNP genotyping of exon 9.
(A and B) PCR ampliﬁcation of genomic DNA was performed using primers
exon9F and IVS9R and resulted in a 405 bp product. PCR product was run
on a 2% agarose gel and visualized by ethidium bromide staining. (C and D)
This was followed by HaeIII restriction enzyme digestion of the PCR
product. The presence of rs55858G created a new HaeIII site and resulted in
a 240 bp fragment, whereas the rs55858A generated for a 307 bp fragment
upon digestion. 1–6 corresponds to samples from the ovaries of six different
mice.
Figure 4: DNA sequences analysis of spliced and unspliced form of Epab.
(A and B) Female mice heterozygous (rs55858A/G) for the exon 9 SNP that inherited the A allele maternally (A) or paternally (B) expressed the spliced variant
(lower frames) from the A allele. (C) In mice homozygous (rs55858G/G) for the exon 9 SNP, mRNA of the spliced variant contained G.
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and D), suggesting that the rs56574G SNP resulted in an increase in
alternative splicing without changing overall of Epab expression.
Discussion
Following their inception within the nucleus, pre-mRNAs undergo
capping at the 50 end and cleavage and polyadenylation at the 30
end, to increase their stability and facilitate their transport into the
cytoplasm (Izaurralde et al., 1994; Flaherty et al., 1997; Zhao et al.,
1999; Proudfoot, 2004). In addition, pre-mRNAs are further processed
by splicing, which consists of the removal of non-essential transcript
sequences termed introns. Splicing requires a 50 splice site that con-
tains a conserved recognition consensus sequence, as well as a discrete
30 splice site that delimits the exon–intron boundary. In between these
two regions, an intronic consensus branch point sequence must be
present to facilitate the reaction (Staley and Guthrie, 1998; Jurica
and Moore, 2003). In addition to these consensus sequences, there
are a number of cis elements located in exons and introns known as
exonic or intronic splicing enhancers or silencers, due to their stimu-
lating or repressing effects, respectively (Liu et al., 1998; Schaal and
Maniatis, 1999; Ladd and Cooper, 2002).
In the current study, we investigated the alternatively spliced form
of Epab lacking exon 10 (c.Ex10del) as a model for alternative spli-
cing in oocytes and early preimplantation embryos. Owing to its
gamete- and early embryo-speciﬁc expression (Seli et al., 2005),
Epab provided a suitable model. To determine the mechanism result-
ing in the observed monoallelic expression of the spliced form of Epab
lacking exon 10,we evaluated imprinting,RNA editing andESEs. The
SNP detected in exon 9 (rs55858A/G) served as a marker for the par-
ental origin of the alternatively spliced form. Neither genomic
imprinting nor RNA editing was responsible for the alternatively
spliced forms of the Epab mRNA (Fig. 4). Another SNP in exon 10,
rs56574G/C, co-segregated with the exon 9 SNP of Epab. We found
that the presence of rs56574G led to the formation of an ESE charac-
teristic for splicing regulatory protein SRp40, resulting in the efﬁcient
exclusion of exon 10. Consequently, in mice heterozygous for the
rs56574G/C SNP, exclusion of exon 10 occurred preferentially from
the allele containing rs56574G, whereas in mice homozygous for
rs56574C, exclusion of exon 10 still occurred, although to a signiﬁ-
cantly lesser extent (Fig. 5A).
ESEs are exonic cis-elements that work with classical splicing
signals (50 splicing site, 30 splicing site and branch site) by binding-
speciﬁc serine/arginine-rich splicing regulatory proteins (SR proteins)
to promote accurate splicing (Birney et al., 1993; Smith and Valcarcel,
2000). SR proteins are characterized by the presence of RNA recog-
nition motifs (RRM) and by a distinctive carboxy terminal domain
thatis highlyenriched in Arg/Serdipeptides(the RSdomain) (Robber-
son et al., 1990). SR proteins binding to ESEs is thought to promote
exon deﬁnition by directly recruiting the splicing machinery through
their RS domain and/or by antagonizing the action of nearby silencer
elements (Cartegni et al., 2002).
We performed sequence analysis of Epab for SR protein-binding
sites using the ESE ﬁnder program (Cartegni et al., 2003). Putative
ESE motifs that agree with the consensus sequences for speciﬁc SR
proteins have high values in the ESE ﬁnder program, and a decrease
in the score relative to a threshold value is indicative of a decrease
or loss of enhancement of transcript splicing (Cartegni et al., 2003).
Although our in silico ﬁndings were highly suggestive of regulation
by ESEs, conﬁrmation was performed using qRT-PCR, which
showed that the presence of rs56574G resulted in a 5-fold increase
in alternative splicing of Epab exon 10 (Fig. 5A).
EPAB plays an important role in the regulation of maternal mRNA
translational activation upon oocyte maturation through both
polyadenylation-dependent and independent mechanisms (Cao and
Richter, 2002; Padmanabhan and Richter, 2006; Vasudevan et al.,
2006).Inaddition,EPABseems toplaya criticalrolebypromotingpro-
tection of the maternal transcripts from deadenylation (Voeltz et al.,
2001; Kim and Richter, 2007). Epab exon 10 encodes for the region of
the EPAB protein that is between the 4th RRM and the C-terminal
PABP domain. In PABPC1, which shows high homology to EPAB,
this region mediates interactions with other proteins. Therefore, the
twoEpabisoformsmayplaydifferentrolesintheregulationofmaternal
mRNA stability and translation. Additional studies will be necessary to
determine whether full length and alternatively spliced forms of Epab
affect translational activation of maternal genes differentially.
ESEs have been shown to regulate alternative splicing in somatic
cells, and exon skipping due to ESEs has been associated with pathol-
ogies such as spinal muscular dystrophy (Lorson et al., 1999). In the
current study, we showed that ESEs are functional in mammalian
oocytes, as they regulate the alternative splicing of Epab. We also
demonstrated that an SNP may result in the formation of an ESE and
Figure 5: Expression of Epab splice variants in mice homozygous rs56574G/
G or rs56574C/C for the exon 10 SNP was quantiﬁed using real-time PCR
(qRT-PCR).
(A) qRT-PCR revealed a 5-fold increase in the expression of the c.Ex10del
variant in the animals carrying the enhancer (homozygous rs56574G/G) for
the exon 10 SNP compared with the mice that did not (homozygous
rs56574C/C) at the same locus (*P , 0.001). (B) The animals that contained
the ESE showed a decrease in the amount of the Epab transcript that contains
exon 10compared withmicethatdid nothave theESE(**P , 0.01).(C) There
was no signiﬁcant difference in the total Epab mRNA content of the two differ-
ent genotypes, suggesting that the rs56574G SNP resulted in an increase in
alternative splicing without changing overall of Epab expression. (D) Relative
ratios of exon 10 unspliced (black) and c.Ex10del (grey) within total Epab
mRNA is shown for animals carrying the enhancer (homozygous rs56574G/
G) for the exon 10 SNP compared with the mice that do not (homozygous
rs56574C/C) at the same locus.
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forms of an oocyte-speciﬁc gene. Further studies will be necessary to
determine whether alterations in gene expression mediated by similar
mechanisms may underlie individual differences in reproductive
function.
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